News
-
-
-
-
PRESS RELEASE
Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Zomedica Corp. reports highest quarterly revenue ever and 19th consecutive year-over-year revenue growth, achieving $8.1M in sales. Record Diagnostics and Therapeutic Device segment performance drive success -
PRESS RELEASE
In a landmark industry transaction, Evotec signs agreement with Sandoz, resulting in payments potentially over US$ 650 m plus royalties
Evotec SE signs landmark agreement with Sandoz, leading to over US$650m in payments plus royalties. Deal includes acquisition of manufacturing site and technology license fees -
PRESS RELEASE
Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse
Sandoz strengthens biosimilars capabilities with acquisition of Just-Evotec Biologics EU SAS in Toulouse. Acquisition aims to capture projected biosimilar market opportunity. Transaction includes cash payment and technology license fees -
-
-
PRESS RELEASE
SMX And CARTIF To Evaluate Potential Collaboration to Accelerate 'Physical-To-Digital' Circular-Economy Innovation Across Spain & Europe
SMX and CARTIF sign non-binding letter of intent to integrate molecular marking technology into sustainability and Industry 5.0 projects. Potential partnership aims to enhance circular economy in Spain and EU -
